Skip to Main Content

Paper Details

Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor.
PLoS One
14
2019
Author NameAffiliation
Steven E FeldonFlaum Eye Institute, University of Rochester
  • 1 - 1

Datasets

Release 1.2